the unique biological properties and therapeutic efficacy of the podophyllotoxin derivatives , vumon ( vm26 , teniposide ) and vepesid ( vp16-213 , etoposide ) , are stimulating the interest of both laboratory and clinical researchers .
C0728981
vumon
C0039512
teniposide